vs

Side-by-side financial comparison of CARLISLE COMPANIES INC (CSL) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

CARLISLE COMPANIES INC is the larger business by last-quarter revenue ($1.1B vs $719.4M, roughly 1.5× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 12.1%, a 61.0% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs -4.0%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $-73.0M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs -14.8%).

Carlisle Companies Incorporated is a supplier of construction products that make buildings more energy efficient and resilient. The company manufactures and sells single-ply roofing products as well as warranted systems and accessories for the commercial building industry. The company is organized into two segments, including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing unde...

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

CSL vs DOC — Head-to-Head

Bigger by revenue
CSL
CSL
1.5× larger
CSL
$1.1B
$719.4M
DOC
Growing faster (revenue YoY)
DOC
DOC
+7.1% gap
DOC
3.1%
-4.0%
CSL
Higher net margin
DOC
DOC
61.0% more per $
DOC
73.2%
12.1%
CSL
More free cash flow
DOC
DOC
$430.0M more FCF
DOC
$357.0M
$-73.0M
CSL
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
-14.8%
CSL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CSL
CSL
DOC
DOC
Revenue
$1.1B
$719.4M
Net Profit
$127.7M
$114.0M
Gross Margin
34.5%
Operating Margin
17.1%
17.4%
Net Margin
12.1%
73.2%
Revenue YoY
-4.0%
3.1%
Net Profit YoY
-10.9%
2406.4%
EPS (diluted)
$3.10
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSL
CSL
DOC
DOC
Q1 26
$1.1B
Q4 25
$1.1B
$719.4M
Q3 25
$1.3B
$705.9M
Q2 25
$1.4B
$694.3M
Q1 25
$1.1B
$702.9M
Q4 24
$1.1B
$698.0M
Q3 24
$1.3B
$700.4M
Q2 24
$1.5B
$695.5M
Net Profit
CSL
CSL
DOC
DOC
Q1 26
$127.7M
Q4 25
$127.4M
$114.0M
Q3 25
$214.2M
$-117.1M
Q2 25
$255.8M
$31.7M
Q1 25
$143.3M
$42.8M
Q4 24
$162.8M
$4.5M
Q3 24
$244.3M
$85.9M
Q2 24
$712.4M
$146.0M
Gross Margin
CSL
CSL
DOC
DOC
Q1 26
34.5%
Q4 25
33.8%
Q3 25
36.0%
58.6%
Q2 25
37.3%
60.2%
Q1 25
35.2%
61.1%
Q4 24
36.1%
60.3%
Q3 24
38.6%
60.0%
Q2 24
39.2%
60.6%
Operating Margin
CSL
CSL
DOC
DOC
Q1 26
17.1%
Q4 25
16.8%
17.4%
Q3 25
21.8%
9.2%
Q2 25
23.1%
5.7%
Q1 25
16.8%
7.7%
Q4 24
19.9%
-2.2%
Q3 24
23.7%
14.1%
Q2 24
26.0%
22.3%
Net Margin
CSL
CSL
DOC
DOC
Q1 26
12.1%
Q4 25
11.3%
73.2%
Q3 25
15.9%
-16.6%
Q2 25
17.6%
4.6%
Q1 25
13.1%
6.1%
Q4 24
14.5%
0.7%
Q3 24
18.3%
12.3%
Q2 24
49.1%
21.0%
EPS (diluted)
CSL
CSL
DOC
DOC
Q1 26
$3.10
Q4 25
$3.06
$0.16
Q3 25
$4.98
$-0.17
Q2 25
$5.88
$0.05
Q1 25
$3.20
$0.06
Q4 24
$3.76
$0.02
Q3 24
$5.25
$0.12
Q2 24
$14.84
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSL
CSL
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$771.3M
$467.5M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$1.7B
$7.5B
Total Assets
$20.3B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSL
CSL
DOC
DOC
Q1 26
$771.3M
Q4 25
$1.1B
$467.5M
Q3 25
$1.1B
$91.0M
Q2 25
$68.4M
$89.4M
Q1 25
$220.2M
$70.6M
Q4 24
$753.5M
$119.8M
Q3 24
$1.5B
$180.4M
Q2 24
$1.7B
$106.9M
Total Debt
CSL
CSL
DOC
DOC
Q1 26
Q4 25
$2.9B
$9.8B
Q3 25
$2.9B
$9.1B
Q2 25
$1.9B
$9.0B
Q1 25
$1.9B
$8.9B
Q4 24
$1.9B
$8.7B
Q3 24
$2.3B
$8.6B
Q2 24
$2.3B
$8.6B
Stockholders' Equity
CSL
CSL
DOC
DOC
Q1 26
$1.7B
Q4 25
$1.8B
$7.5B
Q3 25
$2.0B
$7.6B
Q2 25
$2.1B
$7.9B
Q1 25
$2.2B
$8.2B
Q4 24
$2.5B
$8.4B
Q3 24
$2.8B
$8.6B
Q2 24
$3.0B
$8.8B
Total Assets
CSL
CSL
DOC
DOC
Q1 26
Q4 25
$6.3B
$20.3B
Q3 25
$6.5B
$19.6B
Q2 25
$5.5B
$19.8B
Q1 25
$5.5B
$19.8B
Q4 24
$5.8B
$19.9B
Q3 24
$6.5B
$20.0B
Q2 24
$6.7B
$20.2B
Debt / Equity
CSL
CSL
DOC
DOC
Q1 26
Q4 25
1.61×
1.31×
Q3 25
1.45×
1.20×
Q2 25
0.89×
1.14×
Q1 25
0.87×
1.08×
Q4 24
0.77×
1.04×
Q3 24
0.83×
1.00×
Q2 24
0.76×
0.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSL
CSL
DOC
DOC
Operating Cash FlowLast quarter
$1.3B
Free Cash FlowOCF − Capex
$-73.0M
$357.0M
FCF MarginFCF / Revenue
-6.9%
49.6%
Capex IntensityCapex / Revenue
2.7%
124.4%
Cash ConversionOCF / Net Profit
10.99×
TTM Free Cash FlowTrailing 4 quarters
$924.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSL
CSL
DOC
DOC
Q1 26
Q4 25
$386.0M
$1.3B
Q3 25
$426.9M
$315.0M
Q2 25
$287.1M
$363.5M
Q1 25
$1.8M
$279.4M
Q4 24
$370.6M
$1.1B
Q3 24
$312.8M
$318.2M
Q2 24
$183.4M
$316.2M
Free Cash Flow
CSL
CSL
DOC
DOC
Q1 26
$-73.0M
Q4 25
$346.1M
$357.0M
Q3 25
$393.4M
Q2 25
$258.3M
Q1 25
$-27.2M
Q4 24
$334.0M
$333.7M
Q3 24
$293.5M
Q2 24
$158.5M
FCF Margin
CSL
CSL
DOC
DOC
Q1 26
-6.9%
Q4 25
30.7%
49.6%
Q3 25
29.2%
Q2 25
17.8%
Q1 25
-2.5%
Q4 24
29.7%
47.8%
Q3 24
22.0%
Q2 24
10.9%
Capex Intensity
CSL
CSL
DOC
DOC
Q1 26
2.7%
Q4 25
3.5%
124.4%
Q3 25
2.5%
Q2 25
2.0%
Q1 25
2.6%
Q4 24
3.3%
105.6%
Q3 24
1.4%
Q2 24
1.7%
Cash Conversion
CSL
CSL
DOC
DOC
Q1 26
Q4 25
3.03×
10.99×
Q3 25
1.99×
Q2 25
1.12×
11.48×
Q1 25
0.01×
6.52×
Q4 24
2.28×
235.43×
Q3 24
1.28×
3.71×
Q2 24
0.26×
2.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSL
CSL

CCM$758.0M72%
CWT$294.0M28%

DOC
DOC

Segment breakdown not available.

Related Comparisons